Arrowstreet Capital’s Bausch + Lomb BLCO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$15.6M Sell
982,062
-229,678
-19% -$3.91M 0.01% 816
2025
Q4
$20.7M Buy
1,211,740
+150,047
+14% +$2.38M 0.01% 727
2025
Q3
$16M Sell
1,061,693
-49,846
-4% -$718K 0.01% 809
2025
Q2
$14.5M Sell
1,111,539
-408,316
-27% -$4.91M 0.01% 787
2025
Q1
$22M Buy
1,519,855
+301,424
+25% +$4.95M 0.02% 572
2024
Q4
$22M Buy
1,218,431
+414,138
+51% +$8.08M 0.02% 578
2024
Q3
$15.5M Buy
804,293
+721,512
+872% +$11.9M 0.01% 614
2024
Q2
$1.2M Sell
82,781
-153,361
-65% -$2.3M ﹤0.01% 1187
2024
Q1
$4.08M Buy
236,142
+142,121
+151% +$2.21M ﹤0.01% 951
2023
Q4
$1.6M Buy
94,021
+33,887
+56% +$545K ﹤0.01% 1006
2023
Q3
$1.02M Buy
60,134
+26,411
+78% +$494K ﹤0.01% 987
2023
Q2
$677K Buy
+33,723
New +$612K ﹤0.01% 1025
2023
Q1
Sell
-209,472
Closed -$3.25M 1357
2022
Q4
$3.25M Buy
209,472
+188,011
+876% +$2.82M ﹤0.01% 770
2022
Q3
$329K Buy
+21,461
New +$341K ﹤0.01% 1154

Other funds holding BLCO

Arrowstreet Capital's BLCO Position: Q1 2026 in Review

Arrowstreet Capital reduced its Bausch + Lomb (BLCO) stake by 19% in Q1 2026, selling an estimated $3.91M and leaving 982,062 shares worth $15.6M. The position accounts for 0.01% of the portfolio, ranked #816.

Arrowstreet Capital first reported a position in BLCO in Q3 2022 and has held it in 14 quarters since. The position peaked at $22M in Q1 2025. 96 funds tracked by Wall St. Rank hold BLCO as of Q1 2026.

  • Arrowstreet Capital held 982,062 shares of Bausch + Lomb worth $15.6M as of Q1 2026.
  • Arrowstreet Capital sold 229,678 Bausch + Lomb shares in Q1 2026, an estimated $3.91M.
  • Bausch + Lomb made up 0.01% of Arrowstreet Capital's portfolio in Q1 2026, its #816 holding.
  • Arrowstreet Capital first reported a position in Bausch + Lomb in Q3 2022 and has held it in 14 quarters since.
  • Arrowstreet Capital's Bausch + Lomb position peaked at $22M in Q1 2025.
  • 96 funds tracked by Wall St. Rank held Bausch + Lomb as of Q1 2026.

Based on Arrowstreet Capital's 13F filing for Q1 2026, filed 14 May 2026.